Posted Wednesday 17 October 2018
Australian researchers have developed a novel technique using Maritech® fucoidan to significantly reduce oxidation in microencapsulated fish oils. The breakthrough is expected to revolutionise the delivery of fish oils and other dietary supplements.
Posted Monday 15 October 2018
In an advance that could prove crucial in treating brain injuries, Australian researchers have developed groundbreaking technology involving Maritech® fucoidan to control the body’s own immune response to brain damage.
Posted Friday 21 September 2018
A first-of-its-kind study has investigated the pharmacokinetics of fucoidan, leading to new insights for current and future applications.
Posted Tuesday 4 September 2018
Marinova is pleased to announce its commitment to a 10 year program of research to consolidate the evidence supporting the efficacy of Maritech® fucoidan.
Posted Wednesday 22 August 2018
An algae-based nasal spray offering an adjunct therapy for children with allergic rhinitis has delivered positive interim clinical results.
Posted Thursday 2 August 2018
Australia’s reputation for high quality manufacturing and use of responsibly sourced ingredients, along with strong consumer trust in the Australian brand, is fuelling demand for Australian products and ingredients in China.
Posted Monday 23 July 2018
Research undertaken in the US has demonstrated the powerful anti-viral activity of fucoidan against multiple strains of Avian influenza A, commonly known as bird flu.
Posted Thursday 28 June 2018
The latest edition of Nutracos magazine shines the spotlight on Maritech® fucoidan and the latest findings on its use in immunity, gut health and cancer.
Posted Wednesday 16 May 2018
Brown seaweeds offer significant nutritional benefits, including being a rich source of protein, a new study has confirmed.
Posted Thursday 26 April 2018
Maritech® Bright stars in the latest edition of Personal Care Magazine, highlighting the skin brightening research behind this cosmetic ingredient.
